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Abstract
Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, prolifer-
ation andmetabolism. mTORC1 regulates protein synthesis positively and autophagy nega-
tively. Autophagy is a major system to manage bulk degradation and recycling of cytoplasmic
components and organelles. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric
complex and inactivate Ras homolog enriched in brain, resulting in inhibition of mTORC1. Here,
we investigated the effects of hyperactivation of mTORC1 on cardiac function and structure
using cardiac-specific TSC2-deficient (TSC2-/-) mice. TSC2-/- mice were born normally at the
expectedMendelian ratio. However, the median life span of TSC2-/- mice was approximately 10
months and significantly shorter than that of control mice. TSC2-/- mice showed cardiac dysfunc-
tion and cardiomyocyte hypertrophy without considerable fibrosis, cell infiltration or apoptotic
cardiomyocyte death. Ultrastructural analysis of TSC2-/- hearts revealed misalignment, aggre-
gation and a decrease in the size and an increase in the number of mitochondria, but the mito-
chondrial function wasmaintained. Autophagic flux was inhibited, while the phosphorylation
level of S6 or eukaryotic initiation factor 4E -binding protein 1, downstream of mTORC1, was
increased. The upregulation of autophagic flux by trehalose treatment attenuated the cardiac
phenotypes such as cardiac dysfunction and structural abnormalities of mitochondria in TSC2-/-
hearts. The results suggest that autophagy via the TSC2-mTORC1 signaling pathway plays an
important role in maintenance of cardiac function andmitochondrial quantity and size in the
heart and could be a therapeutic target to maintain mitochondrial homeostasis in failing hearts.
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Introduction
Mammalian target of rapamycin complex 1 (mTORC1) plays a critical role in the regulation of
cell growth, proliferation and metabolism [1]. mTORC1 positively controls protein synthesis
by phosphorylating downstream substrates, namely eukaryotic initiation factor 4E (eIF4E)-
binding protein 1 (4E-BP1) and p70 ribosomal S6 kinase 1 (S6K1). The phosphorylation of
4E-BP1 prevents its binding to eIF4E, enabling eIF4E to promote cap-dependent translation
[2]. Active S6K1 phosphorylates several substrates, including S6, that function in translation
initiation as well as other steps that drive protein production. In addition to protein synthesis,
mTORC1 positively controls mitochondrial function through a yin yang 1-peroxisome prolif-
erator activated receptor coactivator 1alpha (PGC-1alpha) transcriptional complex [3].
On the other hand, mTORC1 also plays an important role in protein degradation. In mam-
malian cells, there are two major systems of protein degradation, namely the ubiquitin/protea-
some system and autophagy. mTORC1 inhibits autophagy [4] by phosphorylating unc-51 like
autophagy activating kinase 1 (ULK1), a mammalian ortholog of Atg1 [5]. In autophagy, an
isolation membrane sequesters a part of the cytoplasm or organelles including mitochondria to
form an autophagosome [6]. The autophagosome fuses with a lysosome and becomes an auto-
lysosome. Then, the materials contained in the autolysosome are degraded by lysosomal
enzymes. Autophagy contributes to macromolecule synthesis and energy production as well as
quality control of cytoplasmic proteins and organelles. We have previously reported that con-
stitutive autophagy in the heart is a homeostatic mechanism for maintaining cardiomyocyte
size, global cardiac structure and function and the quality of mitochondria [7].
Mitochondria are important organelles for ATP production and dynamic organelles. They
continuously undergo fusion and fission during cell life, exhibiting short round-shaped or
elongated morphology. Autophagy will be preceded by mitochondrial fission, which divides
elongated mitochondria into pieces of manageable size for engulfment by isolation membrane.
When autophagy is induced in the cells by nutrient depletion, mitochondria elongate [8]. Elon-
gated mitochondria are spared from autophagy and maintain ATP production upon
starvation.
mTORC1 is positively regulated by Ras homolog enriched in brain (Rheb). Rheb is a small
GTPase, that exists either in an active GTP-bound or an inactive GDP-bound state [9]. In the
signaling pathway towards mTORC1, tuberous sclerosis complex (TSC) 1 and 2 exist upstream
of Rheb. Mutations in either the TSC1 or TSC2 gene are the principal cause of TSC, which is an
autosomal dominant multisystemic disorder characterized by the development of numerous
benign tumours (e.g. hamartomas) in many organs, such as brain, kidneys, skin, heart and
lungs [10]. There is no homology between the 140 kDa TSC1 and the 200 kDa TSC2 proteins.
TSC1 and TSC2 associate with each other to form a heterodimeric complex as a regulatory unit
and a catalytic unit, respectively. The TSC1/2 complex is a GTPase-activating protein that
catalyses the conversion of Rheb-GTP to Rheb-GDP [11] and inactivates Rheb, resulting in
inhibition of mTORC1 signaling [12, 13]. Akt-mediated phosphorylation of TSC2 inhibits the
function of the TSC1/2 complex [14], resulting in activation of mTORC1. However, the exis-
tence of an mTORC1-dependent feedback mechanism blocks growth-factor-stimulated phos-
phorylation of Akt [15].
Studies using Drosophila revealed that loss-of-function mutations of TSC1, TSC2 and both
genes combined lead to organ overgrowth via increased cell proliferation and cell-autonomous
increase in size [16, 17]. In mice, the deficiency of mTORC1 leads to embryonic lethality [18,
19]. Cardiac-specific mTOR-deficient mice are also embryonic lethal [20]. Furthermore, abla-
tion ofMtor in the adult mouse heart results in a fatal, dilated cardiomyopathy, which is mainly
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caused by enhanced dephosphorylation of 4E-BP1 [21]. These data suggest that mTOR has a
critical role in protein synthesis to maintain cardiac function.
To investigate the role of the mTORC1 signaling pathway in the heart, mouse models where
its activity is altered by modulation of upstream signaling molecules will be more physiologi-
cally relevant thanMtor ablation model. We previously investigated the role of mTORC1 in
the heart using cardiac-specific Rheb-deficient mice, where mTORC1 was downregulated [22].
We found that mTORC1 activity through Rheb is essential for normal cardiac hypertrophic
growth during the postnatal period, although autophagy was not related to the phenotypes
observed in Rheb-deficient hearts. Since conventional TSC2-deficient mice are embryonic
lethal [23, 24], we used cardiac-specific TSC2-deficient mice to examine the effect of mTORC1
hyperactivation on protein degradation and mitochondrial dynamics as well as protein synthe-
sis in cardiomyocytes in this study. The ablation of TSC2 in mouse hearts leads to Rheb activa-
tion, mTORC1 activation, ULK1 phosphorylation and then finally inhibition of autophagy.
Our results suggest that autophagy via the TSC-mTORC1 signaling pathway plays an impor-
tant role in determining the size and number of mitochondria to maintain cardiac function.
Materials and Methods
Animals
All in vivo procedures in this study were carried out in accordance with the Guidance on the
Operation of the Animals (Scientific Procedures) Act, 1986 (UK Home Office) or the Guide-
lines for Animal Experiments of Osaka University and the Japanese Act on Welfare and Man-
agement of Animals (No. 105). King’s College London Ethical Review Process Committee and
UK Home Office (Project Licence No. PPL70/7260) or Osaka University Animal Experimenta-
tion Committee approved this study. Mortality was described as a possibility in the approved
study protocols. Mice were given food and water ad libitum. Mice were monitored daily during
the animal study including the survival study to minimize suffering. Animals that showed signs
of significant clinical cardio-respiratory distress due to the development of heart failure (e.g.,
increased respiratory rates, reduced activity, piloerection, hunched posture) were immediately
euthanized by CO2 exposure. In a small pilot study approved by Osaka University Animal
Experimentation Committee and performed under the Guidelines for Animal Experiments of
Osaka University and the Japanese Act onWelfare and Management of Animals (No. 105), 4
mice showed unexpected death (S1 Protocol). Autopsy of all the dead mice showed pleural
effusion and increased lung weight, suggesting the cause of death was heart failure. Thus,
euthanized mice were considered as deaths. All the mice were harvested in the early morning.
We didn’t detect any difference in food consumption and body weight gaining among groups
used in this study.
Generation of cardiac-specific TSC2-deficient mice and
echocardiography
The generation of mice bearing a TSC2flox allele, in which exon 2–4 of the TSC2 gene is flanked
by two loxP sequences, has been previously reported [25]. Mice bearing the TSC2flox allele were
crossed with transgenic mice expressing Cre recombinase under the control of alpha-myosin
heavy chain promoter (alpha-MyHC-Cre) [26]. The genetic backgrounds of the TSC2flox/flox
and alpha-MyHC-Cremice are 129/SvJ x C57B/6J and C57B/6J, respectively. All mice which
were used in this study were male. Vevo 2100 system with a 22–55-MHz linear transducer
(Visual Sonics) was used to perform echocardiography on awake or anaesthetized mice. The
echocardiography was performed on awake mice, those were trained prior to the actual
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measurement. Isoflurane was used for echocardiography on anesthetized mice. The sonogra-
pher blinded to the groups. Trans-thoracic M-mode images were acquired in parasternal short
axis view. Fractional shortening (FS) and end-diastolic left ventricular (LV) mass were calcu-
lated as 100 x (end-diastolic LV internal dimension (LVIDd)—end-systolic LV internal dimen-
sion (LVIDs))/LVIDd and 1.05 x [(LVIDd + end-diastolic interventricular septal thickness
(IVSd) + LV posterior wall thickness (LVPWd))3 - (LVIDd)3], respectively.
Antibodies
Specific antibodies targeted to the following proteins were used for the Western blot analysis in
1,000 times dilution (except for the one to alpha-tubulin (3,000)) and according to manufactur-
ers’ instructions: TSC1 (rabbit monoclonal, Cell Signaling Technology (CST), #6935), TSC2
(rabbit monoclonal, CST, #4308), phosphorylated Akt (rabbit monoclonal, CST, #4058), Akt
(rabbit polyclonal, CST, #9272), phosphorylated AMP-activated protein kinase (AMPK) (rab-
bit monoclonal, CST, #2535), AMPK (rabbit polyclonal, CST, #2532), phosphorylated S6 (rab-
bit, polyclonal, CST, #2215), S6 (rabbit monoclonal, CST, #2217), ubiquitin (rabbit polyclonal,
CST, #3933), microtubule-associated protein 1 light chain 3 (LC3) B (rabbit polyclonal, CST,
#2775), alpha-tubulin (mouse monoclonal, CST, #3873), voltage-dependent anion channel
(VDAC) (rabbit polyclonal, CST, #4866), Parkin (rabbit polyclonal, CST, #2132), 4E-BP1 (rab-
bit polyclonal, Abcam, ab2606), PINK1 (rabbit polyclonal, Abcam, ab23707), KDEL proteins
(mouse monoclonal, Enzo Life Sciences, ADI-SPA-827), sequestosome 1/p62 (p62) (C-termi-
nal specific) (guinea pig polyclonal, Progen, GP62-C), translocase of inner mitochondrial
membrane 23 homolog (Timm23) (rabbit polyclonal, Proteintech, 11123-1-AP), 4-hydroxy-
2-nonenal michael adducts (HNE) (rabbit polyclonal, Calbiochem, 393207). Tissues were lysed
in homogenization buffer (50 mM Tris-HCl, pH 7.4, 150 mMNaCl, 1 mM EDTA, 1 mM
EGTA, 2.5 mM Na-orthovanadate, 2.5 mM Na-pyrophosphate, 1 mM β-glycerophosphate, 1%
Triton X-100) with protease inhibitors (PMSF or protease inhibitor cocktail (Sigma)). Western
blots were incubated with the secondary antibodies, followed by developing with an infrared
imaging system, ODYSSEY CLx (LI-COR). NIH Image J software (version 1.46r) or Image Stu-
dio software (LI-COR) was used to perform densitometric analyses.
Histological analysis
The heart was excised and immediately fixed in buffered 4% paraformaldehyde in PBS, embed-
ded in paraffin, and sectioned to a thickness of 6 micrometers. Haematoxylin and eosin (H&E)
staining was performed on serial sections. For wheat germ agglutinin (WGA) staining, heart
samples were mounted and frozen in O.C.T. compound (Thermo Scientific), cryo-sectioned to
a thickness of 6 micrometers and stained with FITC-conjugated lectin (Sigma) to measure
cross sectional area of cardiomyocytes. To determine the number of cells undergoing nuclear
fragmentation, TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay was performed
on paraffin-embedded heart sections, using In situ Apoptosis Detection Kit (Takara Bio Inc.).
For electron microscopy, the heart was perfused and then fixed with 2% formaldehyde and 2%
glutaraldehyde. LV tissues were processed for transmission electron microscopy. We measured
the area of mitochondria or counted the number of mitochondria in micrographs taken at
10,000-fold magnification, using NIH Image J software (version 1.46r) for 4 fields per mouse.
Quantitative real-time RT-PCR
We isolated total RNA from the LV using the TRIzol reagent (Life Technologies). We deter-
mined mRNA expression levels for atrial natriuretic factor (Nppa), beta-myosin heavy chain
(Myh7), collagen type 1 (Col1a2), Pgc-1a and Gapdh by quantitative RT-PCR. For reverse
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transcription, we used SuperScript II Reverse Transcriptase (Life Technologies). Real-time
PCR reaction was performed using Power SYBR Green Master Mix (Life Technologies) and
PCR primers designed as follows: forward 5’-TCGTCTTGGCCTTTTGGCT-3’ and reverse
5’-TCCAGGTGGTCTAGCAGGTTCT-3’ for Nppa, forward 5’-ATGTGCCGGACCTTGGAA
G-3’ and reverse 5’-CCTCGGGTTAGCTGAGAGATCA-3’ forMyh7, forward 5’-ACGCGGA
CTCTGTTGCTGCT-3’ and reverse 5’-GCGGGACCCCTTTGTCCACG-3’ for Col1a2, for-
ward 5’-AATCAGACCTGACACAACGC-3’ and reverse 5’-GCATTCCTCAATTTCACCA
A-3’ for Pgc-1a and forward 5’-ATGACAACTTTGTCAAGCTCATTT-3’ and reverse
5’-GGTCCACCACCCTGTTGCT-3’ for Gapdh. We constructed real-time PCR standard
curves using the corresponding complementary DNA. All data were normalized to Gapdh
content and are expressed as fold increase over the control group.
Mitochondrial enzyme activities
The activities of NADH cytochrome-c oxidoreductase (complex I + III) and succinate cyto-
chrome-c oxidoreductase (complex II + III) were determined in mitochondrial fractions freshly
isolated from hearts using previously described spectrophotometric methods [27]. Results are
shown as nmol/min/mg protein.
Tissue ATP concentration and the ratio of ADP to ATP
The heart was excised and immediately frozen in liquid nitrogen. The samples were ground
using a pestle and mortar chilled with liquid nitrogen. ATP concentration and the ratio of
ADP to ATP were measured using EnzyLight ADP/ATP Ratio Assay Kit (BioAssay Systems).
Trehalose treatment
To examine the role of autophagy in the development of heart failure in TSC2-/- mice, the mice
were treated with 1% trehalose in drinking water for 10 weeks starting from 6 weeks after birth.
The water solutions were changed twice weekly.
Statistical analysis
Results are shown as the mean ± S.E.M. Paired data were evaluated using a Student’s t-test. The
Kaplan-Meier method with Logrank test was used for survival analysis. Distribution of mito-
chondrial size was analysed using Chi-square or Mann-Whitney U test. A value of P< 0.05
was considered statistically significant.
Results
Generation and characterization of mice lacking TSC2 in the heart
To investigate the effect of the upregulated mTORC1 signaling pathway in the heart, we gener-
ated cardiac-specific TSC2-deficient mice. TSC2flox/flox mice were crossed with mice expressing
alpha-myosin heavy chain promoter driven Cre recombinase (alpha-MyHC-Cre) to obtain
TSC2flox/flox;alpha-MyHC-Cre+ (TSC2-/-) mice. TSC2flox/flox;alpha-MyHC-Cre- (TSC2+/+) litter-
mates were used as controls. The alpha-MyHC-Cre+ mice exhibited similar cardiac function to
their control non-transgenic mice up to 12 months of age [28] and had normal life span. West-
ern blot analysis revealed a 95% reduction of TSC2 protein in cardiomyocytes isolated from
8-week-old TSC2-/- hearts compared with those from TSC2+/+ hearts (Fig 1A). There was sig-
nificant reduction in the expression level of TSC1 protein in TSC2-/- hearts. TSC1 and TSC2
associate with each other to form a heterodimer [29, 30]. Thus, there is a possibility that the
stability of TSC1 is reduced by absence of TSC2. TSC2-/- mice were born normally at the
Mitochondrial Quantity in TSC2-Deficient Hearts
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expected Mendelian ratio (TSC2-/-:TSC2+/+ = 38:43 delivered from crossing TSC2-/- with
TSC2+/+). However, TSC2-/- mice began to die at 4 months of age, and the median life span was
approximately 10 months, which was significantly shorter than that of TSC2+/+ mice (Fig 1B).
The mortality at 4 months was 5%. Autopsy of dead mice showed pleural effusion and
increased lung weight, suggesting the cause for death was heart failure. We evaluated physio-
logical parameters in 4-month-old TSC2-/- mice (Fig 1C). There was no significant difference
in body weight or the ratio of lung to body weight between TSC2-/- and TSC2+/+ mice. The
ratio of whole heart to body weight was significantly higher in TSC2-/- mice. Then, we per-
formed trans-thoracic M-mode echocardiography on awake TSC2-/- mice to evaluate cardiac
morphology and function (Fig 1D). Heart rate (HR), IVSd and LVPWd were significantly
reduced and LVIDd and LVIDs were significantly increased in TSC2-/- mice compared with
those in TSC2+/+ mice. Furthermore, FS, an indicator of cardiac systolic function, was signifi-
cantly lower and calculated LV mass was significantly increased in TSC2-/- mice compared
with those in TSC2+/+ mice. Since there was a possibility that reduced HR was the cause for
reduction of systolic function in TSC2-/- mice, we performed echocardiography on anaesthe-
tized mice to obtain the data under the same HR (S1 Fig). Under the situation, TSC2-/- mice
showed increase in LV chamber size and decrease in LV contractility. Histological analysis by
H&E staining indicated no significant fibrosis or cell infiltration (Fig 2A). WGA staining
showed a significant increase in the cross-sectional area of cardiomyocytes in TSC2-/- mice
Fig 1. Development of cardiac dysfunction in cardiac-specific TSC2-deficient mice. (A): Western blot analysis of TSC proteins in adult cardiomyocytes
isolated from 8-week-old TSC2+/+ and TSC2-/- mice. (B): Survival curve of the mice. (C): Physiological analysis of the mice at 4 months of age. BW, HW/BW,
and Lung/BW indicate body weight, whole heart-to-body-weight ratio, and lung-to-body-weight ratio, respectively. (D): Echocardiographic analysis of the
awake mice at 4 months of age. (E): Physiological analysis of the mice at 4 weeks of age. (F): Echocardiographic analysis of the awake mice at 4 weeks of
age. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 5–6 samples in (A), from 20
mice in (B), from 7–8 mice in (C), from 9 mice in (D), from 5–7 mice in (E) and from 3–5 mice in (F) in each group. *P < 0.05 versus corresponding control.
doi:10.1371/journal.pone.0152628.g001
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compared with that in TSC2+/+ mice (Fig 2B and 2C). There was no significant difference in
number of TUNEL-positive cardiomyocytes between the two groups (Fig 2E). Quantitative
RT-PCR analyses showed higher mRNA expression levels of Nppa andMyh7, markers for car-
diac remodeling, but not that of Col1a2, a marker for fibrosis, in TSC2-/- hearts (Fig 2G) in
agreement with the histological analyses. These data indicate that TSC2-/- mice showed cardio-
myocyte hypertrophy, LV chamber dilatation and cardiac dysfunction without considerable
fibrosis, pulmonary congestion or apoptotic cardiomyocyte death at 4 months of age.
Biochemical features related to the mTORC1 signaling pathway in
4-month-old TSC2-/-mice
We examined the effect of TSC2 ablation on the mTORC1 signaling pathway in 4-month-old
mouse hearts (Fig 3A). TSC1 was significantly decreased in TSC2-/- hearts although the differ-
ence was smaller compared to that in isolated cardiomyocytes. There were significant increases
in the phosphorylation levels of S6 and 4E-BP1 in TSC2-/- hearts compared with TSC2+/+
Fig 2. Development of cardiac hypertrophy in TSC2-/- mice. The data at 4 months of age in (A) to (C), (E)
and (G). The data at 4 weeks of age in (D), (F) and (H). (A): Haematoxylin and eosin (H&E)-stained heart
sections. (B): Wheat germ agglutinin (WGA)-stained heart sections. (C) and (D): Cardiomyocyte cross-
sectional area was measured by tracing the outline of 100 myocytes in each section. (E) and (F): Number of
TUNEL-positive cardiomyocytes. (G) and (H): mRNA expressions of Nppa,Myh7 andCol1a2were
determined by quantitative RT-PCR. Data were normalized to theGapdh content and are expressed as fold
increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice,
respectively. Values represent the mean ± S.E.M. of data from 4 mice in (C) and (E), from 3 mice in (D) and
(F), from 3–4 mice in (G) and from 4–5 mice in (H) in each group. *P < 0.05 versus control group. Scale bars,
50 micrometers.
doi:10.1371/journal.pone.0152628.g002
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hearts, indicating the activation of mTORC1 and resultant upregulation of protein synthesis in
TSC2-/- hearts. The phosphorylation level of Akt was significantly decreased in TSC2-/- hearts
compared with TSC2+/+ hearts, which is consistent with the existence of a negative feedback
loop [31]. AMPK is a positive regulator of TSC2 protein, and its activation in response to a
decrease in ATP and an increase in AMP in cytosol leads to TSC2 phosphorylation [1]. The
phosphorylation level of AMPK was significantly decreased in TSC2-/- group although the
expression level of AMPK was increased. To evaluate the accumulation of ubiquitinated, mis-
folded or unnecessary proteins due to the excess of protein synthesis, we performedWestern
blot analyses for ubiquitin and KDEL proteins (GRP78 and GRP94), markers for endoplasmic
Fig 3. Upregulation of the mTORC1 signaling pathway in TSC2-/- hearts. The data at 4 months of age in (A) to (C). The data at 4 weeks of age in (D) to
(F). (A) and (D): Western blot analysis of signaling proteins upstream or downstream of mTORC1 in the heart of TSC2+/+ or TSC2-/- mice. p-Akt, t-Akt, p-
AMPK, t-AMPK, p-S6 and t-S6 indicate phosphorylated Akt, total Akt, phosphorylated AMPK, total AMPK, phosphorylated S6 and total S6, respectively. Data
of phosphorylated proteins were normalized to corresponding total protein content, TSC1 and t-AMPK to alpha-tubulin and gamma-form to total 4E-BP1 (t-
4E-BP1), respectively. (B) and (E): Western blot analyses of KDEL and ubiquitinated proteins. (C) and (F): Western blot analyses of LC3 and p62. Data were
normalized to the alpha-tubulin protein. All data are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+
and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–7 mice in each group. *P < 0.05 versus corresponding control.
doi:10.1371/journal.pone.0152628.g003
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reticulum stress (Fig 3B). However, we detected no significant differences in the expression lev-
els of the proteins between the two groups. Since mTORC1 is known to be a negative regulator
of autophagy in mammalian cells [4], we estimated the autophagic activity in TSC2-/- hearts
(Fig 3C) [32]. The conversion of LC3-I to LC3-II is an essential step for autophagosome forma-
tion. The expression level of LC3-II was not significantly different between the two groups.
However, p62, a marker for autophagic flux, was significantly accumulated in TSC2-/- hearts
compared to TSC2+/+ hearts.
Mitochondrial morphology in 4-month-old TSC2-/- hearts
Mitochondria are the major source of energy production in cells and mTORC1 controls mito-
chondrial activity and biogenesis [33]. Therefore, we investigated the morphology of mito-
chondria using transmission electron microscopy. Ultrastructural analysis of TSC2-/- hearts
showed misalignment, aggregation and a decrease in size of mitochondria (Fig 4A), but the
intra-mitochondrial structure appeared to be maintained, as shown in the image insets. The
frequency of smaller mitochondria was significantly increased in TSC2-/- hearts and the num-
ber of mitochondria per area was significantly bigger in TSC2-/- hearts compared with TSC2+/+
hearts (Fig 4B). Dysfunctional mitochondria generate reactive oxygen species. We estimated
the amount of HNE proteins, which is a marker for oxidative stress, in the mitochondrial frac-
tion (Fig 4C). The amount was significantly increased in TSC2-/- hearts, suggesting the accu-
mulation of oxidative stress. However, PINK1 and Parkin, molecules related to mitophagy was
decreased (Fig 4D) and total mitochondrial amount in the heart indicated by the levels of mito-
chondria-specific proteins, such as VDAC (a marker for outer membrane) and Timm23 (a
marker for inner membrane) was not different between the two groups (Fig 4E).
Protein synthesis and autophagic activities in 4-week-old TSC2-/- hearts
To investigate the mechanism underlying cardiac dysfunction and mitochondrial morphologic
changes in TSC2-/- mice, we examined cardiac phenotypes of the mice at an earlier time point,
when the secondary effects caused by cardiac dysfunction were minimal. We selected 4 weeks
of age to minimize the effects of rapid growth, although the mice had already showed cardiac
dysfunction estimated by echocardiography on awake mice (Fig 1F). The wall thickness indi-
cated by IVSd and LVPWd was not different between the two groups (Fig 1F) in contrast to the
4-month-old mice. The mortality at 4 weeks was 0% (Fig 1B). As we observed in 4-month-old
TSC2-/- mice, HW/BW was increased (Fig 1E), CSA was increased (Fig 2D), apoptosis was not
changed (Fig 2F), the expression level of Nppa was increased and that of Col1a2 was not
changed (Fig 2H) in 4-week-old TSC2-/- mice. The expression level ofMyh7 was not changed,
while it was increased in 4-month-old TSC2-/- mice. These data suggest the progression of car-
diomyopathy in TSC2-/- mice with time. In Western blot analysis, the phosphorylation level of
Akt was significantly decreased and those of S6 and 4E-BP1 were significantly increased in the
heart of TSC2-/- mice compared with those of TSC2+/+ mice (Fig 3D). There was no significant
difference in the level of KDEL or ubiquitinated proteins (Fig 3E). These are the same changes
as observed in 4-month-old TSC2-/- mice. In contrast to the 4-month-old hearts, the level of
phosphorylated AMPK was significantly decreased in TSC2-/- hearts, and the expression level
of TSC1 showed no significant difference (Fig 3D). The protein level of p62 was significantly
increased in TSC2-/- hearts, as observed in 4-month-old TSC2-/- mice. The protein level of
LC3-II was increased (Fig 3F), while that showed no significant increase in 4-month-old
TSC2-/- mice. These suggest that the autophagic flux was attenuated due to impairment of
autophagosome removal.
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Mitochondrial morphology and function in 4-week-old TSC2-/- hearts
Ultrastructural analysis revealed a decrease in size and an increase in number of mitochondria
in 4-week-old TSC2-/- hearts (Fig 4F and 4G), as observed in the 4-month-old hearts. As
impaired mitochondrial function might be a cause for the cardiac dysfunction seen in TSC2-/-
mice, we examined mitochondrial function by measuring respiratory chain enzyme activity in
mitochondria isolated from mouse hearts (Fig 5A). However, there was no significant differ-
ence in the activity of either complex I + III or complex II + III between the two groups. We
estimated the amount of HNE proteins in the mitochondrial fraction (Fig 4H). There was no
significant difference in the protein level between the two groups, although that was increased
Fig 4. Morphological abnormality in mitochondria of TSC2-/- hearts. The data at 4 months of age in (A) to (E). The data at 4 weeks of age in (F) to (I). (A)
and (F): Electron micrographs of TSC2+/+ and TSC2-/- mouse hearts. Intramitochondrial structure is shown in the insets. (B) and (G): Quantitative analysis of
mitochondria in size and number. (C) and (H): Western blot analysis of HNE proteins in the mitochondrial fraction isolated from the heart. VDAC is used as
loading control. (D) and (I): Western blot analysis of proteins related to mitophagy. (E): Western blot analysis for mitochondrial proteins. Data were
normalized to the VDAC or alpha-tubulin protein content and are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars
represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–5 mice in each group. *P < 0.05 versus corresponding
control. Scale bars: 2 micrometers in (A); 1 micrometer in insets of (A).
doi:10.1371/journal.pone.0152628.g004
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in 4-month-old TSC2-/- mice. The expression levels of PINK1 and Parkin were decreased (Fig
4I) as observed in 4-month-old TSC2-/- mice. Furthermore, we examined ATP concentration
and the ratio of ADP to ATP concentration (ADP/ATP) in the heart tissue (Fig 5B). ATP con-
centration was found to be significantly increased in TSC2-/- hearts compared with TSC2+/+
hearts, and a significant decrease in ADP/ATP was detected. The mRNA expression of Pgc-1a
measured by quantitative RT-PCR was preserved in TSC2-/- hearts (Fig 5C). These data indi-
cate that the mitochondrial function was maintained in TSC2-/- hearts, although mitochondrial
morphology was changed. Thus, the main cause of the cardiac phenotype seen in TSC2-/- hearts
is not mitochondrial dysfunction.
Attenuation of the cardiac phenotypes in TSC2-deficient hearts by
upregulation of autophagic flux
We hypothesized that reduced autophagic flux is one of the mechanisms for the cardiac pheno-
types seen in TSC2-/- mice. To investigate the involvement of autophagy in cardiac phenotypes
in TSC2-/- hearts, we treated the TSC2-/- mice with trehalose. Trehalose is a non-reducing disac-
charide found in a wide variety of organisms, including bacteria, yeast, invertebrates, and
plants and functions to protect cells against various environmental stresses [34]. Recently, it is
reported that trehalose acts as an mTOR-independent autophagy activator and can reduce pro-
tein aggregates in some mouse disease models [35–37]. First, we treated TSC2+/+ mice with tre-
halose for 10 weeks starting from 6 weeks after birth to confirm upregulation of autophagic
activity. Western blot analysis for LC3 indicated that autophagy was upregulated (Fig 6A).
Thus, we treated TSC2-/- mice with trehalose for 10 weeks starting from 6 weeks after birth.
After the treatment, cardiac function indicated by echocardiographic fractional shortening was
significantly improved in the trehalose-treated group compared with control non-treated
group (Fig 6B). The heart weight and the ratio of heart to body weight were not different
between the two groups (Fig 6C). The accumulation of p62 was significantly reduced in treha-
lose-treated TSC2-/- hearts compared with control TSC2-/- hearts, although the protein level of
Fig 5. Biochemical analyses of mitochondrial function in TSC2-/- hearts at 4 weeks of age. (A): The
activities of complex I + III and complex II + III in mitochondria isolated from the hearts. (B): The ATP content
expressed as fold increase over levels in the TSC2+/+ group and ADP to ATP ratio (ADP/ATP) in the heart
tissues. (C): mRNA expression of Pgc-1awas determined by quantitative RT-PCR. Data were normalized to
theGapdh content and are expressed as fold increase over levels in the TSC2+/+ group. Values represent the
mean ± S.E.M. of data from 3–4 mice in each group. Open and closed bars represent TSC2+/+ and TSC2-/-
mice, respectively. *P < 0.05 versus corresponding control.
doi:10.1371/journal.pone.0152628.g005
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LC3-II was not different (Fig 6D). This supports that trehalose increased autophagic flux in
TSC2-/- mice. Ultrastructural analysis showed that the size of mitochondria was larger and the
number was smaller in trehalose-treated group than those in control group (Fig 6E and 6F).
Discussion
In this study, we showed that the TSC-mTORC1 signaling pathway plays an important role to
maintain cardiac function and to regulate mitochondrial size and number. Its homeostatic
function is mediated through autophagy. Since mitochondria were not damaged in TSC2-/-
hearts, autophagy is the main player in this system rather than mitochondria-specific autop-
hagy, mitophagy.
It has been reported that cardiac-specific TSC1-deficient mice, which were generated by
crossing floxed TSC1mice with myosin light chain 2v-promotor driven Cre recombinase
knock-in mice, had a median survival of 6 months and developed dilated cardiomyopathy [38].
Since TSC1 is required to stabilize TSC2 and prevents its ubiquitin-mediated degradation [29,
30], ablation of TSC1 would lead to downregulation of TSC2. It is reasonable that TSC1-defi-
cient mice developed similar cardiac phenotypes to TSC2-/- mice. Thus, the TSC1/2 complex is
essential for maintenance of cardiac function after birth, but not for heart development or
Fig 6. Effects of trehalose treatment on cardiac phenotypes in TSC2-/- mice. (A): Western blot analysis for LC3 in trehalose-treated TSC2+/+ group. Data
were normalized to alpha-tubulin protein content. White and light gray bars represent control TSC2+/+ mice and trehalose-treated TSC2+/+ mice, respectively.
(B): Echocardiographic parameters of the awake TSC2-/- mice. (C): Physiological parameters of the TSC2-/- mice. BW, HW and HW/BW indicate body weight,
whole heart weight and whole heart-to-body-weight ratio, respectively. (D): Western blot analysis for LC3 and p62. Data were normalized to alpha-tubulin
protein content. All data are expressed as fold increase over levels in control TSC2-/- group. (E and F): Electron micrographs of the TSC2-/- hearts (E) and
quantitative analyses of mitochondrial size and number (F). In (B) to (F), black and dark gray bars represent control TSC2-/- mice and trehalose-treated
TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3 to 5 mice in each group. *P < 0.05 versus control group. Scale bars: 2
micrometers.
doi:10.1371/journal.pone.0152628.g006
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survival during embryonic stage. Although the molecular mechanisms underlying the develop-
ment of dilated cardiomyopathy in the TSC1-deficient mice have not been investigated, histo-
logical analysis of the mice showed the occurrence of scattered foci of enlarged cardiomyocytes
accumulating glycogen without any evidence of proliferation in the lesion [38]. However, we
did not observe such histological changes nor tumorigenesis in TSC2-/- hearts macroscopically
and by echocardiography. Although the molecular mechanism underlying the difference in the
histological findings between cardiac-specific TSC1 and TSC2-deficient hearts is unknown, it
may be due to the timing of gene knockdown or distinct functions of the products of these
genes.
TSC2 ablation in the heart led to not only cardiac dysfunction, but also a decrease in heart
rate. ATP is released from cardiomyocytes [39, 40] and immediately metabolized to adenosine
by ATPases that have their catalytic domain on the outer side of plasma membrane. Since
adenosine is known to have a negative effect on heart rate [41], increased cytosolic ATP level
may result in a decrease in heart rate in TSC2-/- mice. Other possibilities are that histological
abnormalities including misalignment of mitochondria or direct effects of the TSC2 signaling
pathway impair the function of the conduction system in the heart.
Autophagic flux indicated by protein level of LC3-II and p62 was decreased in TSC2-/-
hearts at 4 weeks of age. Co-existence of increased LC3-II with increased p62 protein levels is
consistent with impaired autophagosome removal rather than decreased formation. mTORC1
has been reported to regulate autophagy by signalling to ULK1 and lysosome homeostasis [5,
42].
We observed cardiomyocyte hypertrophy indicated by increases in heart-to-body weight
ratio, LV mass and cross-sectional area of cardiomyocytes in TSC2-/- mice. Absence of fibrosis
and cardiomyocyte death indicates that cardiac remodeling observed in TSC2-/- mice is not typ-
ical for general dilated cardiomyopathy. The hypertrophic responses can be induced by activa-
tion of protein synthesis. We previously reported that inhibition of autophagy in
cardiomyocytes leads to cardiac hypertrophy [7]. In this study, as the treatment with trehalose
had no effect on cardiac hypertrophy, the results suggest that inhibition of autophagy is not
involved in the development of cardiac hypertrophy in TSC2-/- mice.
Our previous results showed that inhibition of autophagy in the heart by ablation of Atg5
induced misalignment and heterogeneous size of mitochondria and damage of intramitochon-
drial structure, impaired mitochondrial function and increased oxidative stress [7, 28]. If we
consider the importance of autophagy for maintenance of normal functional mitochondria, it
is surprising that TSC2-/- hearts showed normal mitochondrial respiratory function even with
alteration in mitochondrial number and size. The normal mitochondrial function was con-
firmed by the results that ATP content was not decreased and oxidative stress was not
increased in TSC2-/- hearts. This is in agreement with the previously reported in vitro studies
that mitochondrial activity is stimulated and ATP levels are increased under the condition of
constitutive mTORC1 activation in TSC2-deficient or knockdown cells [33, 43, 44]. The TSC2/
mTORC1-dependent autophagy pathway may not be required for the removal of damaged
mitochondria at least in the absence of TSC2. However, the mitochondrial function was mea-
sured using isolated mitochondria in this study and the assay has experimental limitation. It
has been reported that isolation of mitochondria causes the difference in functional character-
istics compared to intact mitochondria in permeabilized miofibers [45]. mTORC1 is reported
to control mitochondrial ATP production capacity by selectively promoting translation of
nucleus-encoded mitochondria-related mRNA [33]. Hyperactivation of mTORC1 may protect
mitochondria against stress. We observed an increase in number and a decrease in size of mito-
chondria in TSC2-/- hearts. Consistent with our findings, the number of mitochondria is
increased in pancreatic beta-cells lacking TSC2 [44]. The quantity, quality and size of
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mitochondria are determined by fusion and fission, followed by autophagy [46]. It is possible
that the TSC2/mTORC1-dependent signaling pathway may be directly or indirectly involved
in mitochondrial dynamics.
The activation of AMPK leads to TSC2 phosphorylation, resulting in restoration of ATP
through regulation of metabolism and inhibition of growth via the mTORC1 pathway. AMPK
phosphorylation was impaired in our TSC2-/- hearts, conversely the level was reported to be
increased in tumor-derived cells or neurons lacking TSC2 [47, 48]. The phosphorylation level
of AMPK in TSC2-/- hearts may be affected by the increase in intracellular ATP concentration.
AMPK activates autophagy not only by inhibition of mTORC1 but also by direct phosphoryla-
tion of ULK1, which is required for autophagy induction [5, 48, 49]. In addition to activation
of mTORC1 activity, inhibition of AMPK activity may supress autophagic activity in TSC2-/-
hearts. Although the decreased Akt phosphorylation level in TSC2-/- hearts can inhibit
mTORC1 via proline-rich Akt substrate of 40 kDa (PRAS40), an endogenous mTORC1 inhibi-
tor, the negative feedback mechanism would not be enough for the normalization of the
mTORC1 signaling pathway.
mTORC1 positively regulates cell growth and proliferation by promoting biosynthesis of
proteins and lipids and mitochondrial metabolism and biogenesis and also by limiting autop-
hagy [1]. Over-activating these functions of mTORC1 could be related to the observed pheno-
types in TSC2-/- hearts. mTOR controls mitochondrial oxidative function through a yin yang
1‒PGC-1alpha transcriptional complex [3]. PGC-1alpha is known to promote mitochondrial
biogenesis and function. In TSC2-/- hearts, mitochondrial function was maintained, ATP con-
centration was increased and the expression of PGC-1alpha was preserved. Therefore, we can
exclude the possibility that impairment of mitochondrial metabolism and biogenesis is a cause
for cardiac dysfunction in TSC2-/- mice.
We previously reported that inhibition of autophagy by cardiac-specific Atg5-deficient mice
induces age-related cardiomyopathy [28] and it was found that the accumulation and aggrega-
tion of damaged or unnecessary proteins could cause the malfunction of biological processes
and play an important role in aging. As signaling pathways towards protein synthesis were sig-
nificantly accelerated in TSC2-/- hearts, there is a possibility that unnecessary or misfolded pro-
teins were accumulated in cardiomyocytes to induce cardiac dysfunction. However, we
observed no increase in ubiquitinated or KDEL proteins in TSC2-/- hearts. Some compensatory
mechanisms, such as TSC2/mTORC1-independent autophagy, chaperone-mediated autop-
hagy and proteasome system, could be involved in the maintenance of protein turnover. It is
also possible that the ability of mTORC1-dependent autophagy still might be enough to
respond to the increased protein load.
PINK1 and Parkin are known to be key molecules for damaged mitochondria clearance via
ubiquitination and mitophagy in neuron [50]. Surprisingly, the expression level of PINK1 and
Parkin was reduced in TSC2-/- hearts, suggesting PINK1 and Parkin-related mitophagy is
down-regulated. Although it was reported that suppression of mTOR pathway can increase the
expression level of PINK1 and Parkin [51], it is unclear why PINK1 and Parkin are reduced in
this model. Further study is requested to clarify the effect of the decreases in PINK1/Parkin lev-
els on the cardiac phenotype and mitochondrial morphology observed in TSC2-/- mice.
The protein level of p62 was significantly decreased by treatment of trehalose for 10 weeks,
suggesting that autophagic flux was improved by trehalose treatment. However, the protein
level of LC3-II was not different between control and trehalose-treated TSC2-/- groups. This
might be due to the balance between the upregulation of autophagic induction and autolysoso-
mal removal. The protective effect of trehalose on cardiac dysfunction in TSC2-/- mice indicates
the existence of an mTOR-independent pathway to enhance autophagic flux. Upregulation of
autophagic activity by trehalose treatment improved the cardiac function, indicating that
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downregulation of autophagy could be a significant cause for cardiac phenotypes in TSC2-/-
mice. Since the extent of rescue of the cardiac phenotypes was partial, we could not exclude
possibilities that mechanisms other than autophagy are involved in the development of cardiac
phenotypes in TSC2-/- mice. Trehalose is not a selective activator of autophagy [34]. Further-
more, trehalose does not appear to be absorbed and is rather broken down to glucose in the
gastrointestinal tract of mammals [52]. Thus, we cannot exclude a possibility that improve-
ment in cardiac function is due to the other potential “off-target” effects of trehalose. Molecular
mechanisms how downregulation of autophagic flux in TSC2-/- mice resulted in the
impairment of cardiac function remain to be elucidated. Cytoarchitectural disorganization
would lead to cardiac dysfunction [53]. Ultrastructural images of TSC2-/- hearts showed mis-
alignment of mitochondria and looked as if many of mitochondria could not interact with
myofibril closely, suggesting that energy transfer between mitochondria and myosin-ATPase
could be restricted. Activated autophagy can remove not only small mitochondria but also
other cytoplasmic components and improve the interaction and energy transfer between mito-
chondria and myofibril. It is also possible that the misaligned mitochondria simply disturb sar-
comere contraction.
In conclusion, we demonstrated that constitutive stimulation of mTORC1 signaling by
TSC2 ablation in the heart leads to cardiac chamber dilatation and dysfunction and that upre-
gulation of autophagic activity attenuates the cardiac dysfunction. Autophagy regulated by
TSC-mTORC1 signaling in the heart is essential for the control of mitochondrial quantity. It is
reported that mTORC1 inhibitors such as rapamycin can be pharmacological treatments of
TSC disease [54, 55]. Trehalose could be a novel therapeutic for TSC patients. However, further
investigation is required to reveal the involvement of autophagy in the pathogenesis of the dis-
ease with benign tumours.
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